The impact of the unfolded protein response on human neurons carrying the familial Alzheimer's disease PSEN1-deltaE9 mutation by Chen, Andrew G.
UC San Diego
UC San Diego Electronic Theses and Dissertations
Title
The impact of the unfolded protein response on human neurons carrying the familial 
Alzheimer's disease PSEN1-deltaE9 mutation
Permalink
https://escholarship.org/uc/item/12d3h5dt
Author
Chen, Andrew G.
Publication Date
2017
 
Peer reviewed|Thesis/dissertation
eScholarship.org Powered by the California Digital Library
University of California
 
 
 
UNIVERSITY OF CALIFORNIA, SAN DIEGO 
 
 
The impact of the unfolded protein response on human neurons carrying the familial 
Alzheimer's disease PSEN1-deltaE9 mutation 
 
A Thesis submitted in partial satisfaction of the requirements 
for the degree Master of Science 
 
 
in 
 
Biology 
 
by 
 
Andrew Chen 
 
 
Committee in Charge: 
 Professor Lawrence Goldstein, Chair 
 Professor Shelley Halpain, Co-Chair 
 Professor Maho Niwa Rosen 
 
 
 
2017
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright 
Andrew Chen, 2017 
All rights reserved 
 
 
iii 
 
 
 
 
 
The Thesis of Andrew Chen is approved, and it is acceptable in quality and form for 
publication on microfilm and electronically: 
 
 
 
 
 
 
 
Co-Chair 
 
 
 
Chair 
 
 
University of California, San Diego 
 
 2017  
 
 
iv 
 
DEDICATION 
I dedicate this thesis to my mother, for instilling in me my love of science and biology, 
and for her unconditional love and support.  
 
 
 v 
TABLE OF CONTENTS 
 
Signature Page............................................................................................................. iii 
Dedication...................................................................................................................  
Table of Contents........................................................................................................ 
List of Figures............................................................................................................. 
List of Tables............................................................................................................... 
Acknowledgements..................................................................................................... 
Abstract of Thesis........................................................................................................ 
Introduction................................................................................................................. 
Results......................................................................................................................... 
Discussion................................................................................................................... 
Materials and Methods................................................................................................ 
References................................................................................................................... 
iv 
v 
vi 
vii 
viii 
x 
1 
9 
31 
38 
43
 
  
 
 
 vi 
LIST OF FIGURES 
Figure 1. The Unfolded Protein Response................................................................. 
 
Figure 2. Tunicamycin induces death in a dose- and time-dependent manner in 
control NSCs.............................................................................................................. 
 
Figure 3. PS1-ΔE9 NSCs differ in viability in response to tunicamycin-induced 
ER stress..................................................................................................................... 
 
Figure 4. Control neurons are more resilient to tunicamycin-induced ER stress 
than NSCs.................................................................................................................. 
 
Figure 5. Tunicamycin induces elevated transcription of ER stress genes without 
reducing cellular viability.......................................................................................... 
 
Figure 6. PS1-∆E9 neurons are marginally more sensitive to ER stress-induced 
death........................................................................................................................... 
 
Figure 7. PS1-∆E9 neurons are less sensitive to thapsigargin-induced ER stress 
cell death.................................................................................................................... 
 
Figure 8. PS1-∆E9 neurons express different levels of ER stress genes compared 
to wild type neurons................................................................................................... 
 
Figure 9. Tunicamycin-induced ER stress does not change the Aβ42/Aβ40 ratio.... 
 
Figure 10. Extended treatment of neurons with tunicamycin does not affect 
Aβ42/Aβ40 ratio, but does decrease both Aβ42 and Aβ40....................................... 
 
Figure 11. Thapsigargin-induced ER stress does not change the Aβ42/Aβ40 ratio.. 
 
Figure 12. Extended treatment of neurons with thapsigargin does not affect the 
Aβ42/Aβ40 ratio in wild type or PS1-∆E9 neurons, but decreases Aβ42 and Aβ40 
in wild type neurons................................................................................................... 
 
Figure 13. ER stress induced for two days reduces p-tau/t-tau ratio in PS1-∆E9 
neurons....................................................................................................................... 
 
Figure 14. Prolonged induction of ER stress by tunicamycin reduces P-tau/T-tau 
ratio by decreasing P-tau............................................................................................ 
18 
 
 
19 
 
 
20 
 
 
21 
 
 
21 
 
 
22 
 
 
23 
 
 
24 
 
25 
 
 
26 
 
27 
 
 
 
28 
 
 
29 
 
 
30
 
 
 
 
 
vii 
 
LIST OF TABLES 
Table 1. Primers used for qPCR................................................................................ 42
  
 
 
viii 
 
ACKNOWLEDGEMENTS 
 First and foremost, I would like to express my deepest gratitude to Dr. Larry 
Goldstein for accepting me into his lab and participate in one of the greatest learning 
experiences of my life. I have learned so much during my time here, about Alzheimer’s 
disease, about the trials and tribulations of research, and about myself.  
I would also like to thank Dr. Shelley Halpain and Dr. Maho Niwa Rosen for 
taking time out of their schedules serving on my committee. 
 Next I want to thank my mentor, Dr. Angels Almenar-Queralt, for her continued 
guidance and support during my time here. Her mentorship, both in lab and in life have 
played a pivotal role in my growth as a student researcher and as a person out of lab. 
Next I would like to all the members of the Goldstein lab, past and present, for their 
amazing positivity, quirkiness, and endless energy, day in and day out. To be surrounded 
by such intelligent and kind people for two years was truly a blessing, and made my time 
here even more unforgettable. I would especially like to thank Dr. Rodrigo dos Santos 
Chaves for the random check-ups with how my research was progressing, and for 
engaging in random, late-night discussions during tissue culture; Cheryl Herrera for 
helping me get situated in the lab when I first joined; Dr. Paulina Ordonez and Dr. 
Bridget Kohlnhofer for their helpfulness and energy to keep things exciting. I would also 
like to extend my thanks to Dr. Ella Tour for her assistance in the preparation of this 
written thesis.  
I would like to thank all my friends and family for their continued support and 
encouragement. Their continued support and positivity kept me going as I pursued my 
graduate degree. 
 
 
ix 
 
Finally, I would like to thank my mom, for her unconditional love and support 
throughout my life, for instilling in me my love of science, and for being the greatest role 
model I have ever had. Nothing that I have accomplished up to today and in the future, 
would be possible without her.   
 
 
x 
 
 
 
 
ABSTRACT OF THESIS 
 
 
The impact of the unfolded protein response on human neurons carrying the familial 
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Alzheimer’s disease (AD) is characterized by extensive cell death and 
accumulation of misfolded proteins in the brain, which consist of amyloid beta (Aβ) 
plaques and hyperphosphorylated tau neurofibrillary tangles (NFTs). We sought to 
determine the effects of endoplasmic reticulum (ER) stress on classical AD 
characteristics in neurons and neural stem cells (NSCs). We used isogenic human 
 
 
xi 
 
induced pluripotent stem cell (hiPSC)-derived neurons and NSCs that were genetically 
modified with the presenilin 1 exon 9 deletion (PS1-ΔE9) mutation. We found that after 
two days, tunicamycin induced cell death in the PS1-ΔE9 neurons, but not wild type 
neurons; treatment for five days with thapsigargin, however, induced more cell death in 
wild type neurons than PS1-∆E9 neurons. 
While previous studies have suggested connections between ER stress, Aβ, and 
phosphorylated tau (P-tau), results have remained controversial. To measure the effects 
of ER stress on Aβ42/Aβ40 and P-tau/T-tau (total tau) ratios, we treated neurons with 
tunicamycin or thapsigargin for two or five days. We observed no change in Aβ42/Aβ40 
ratio with tunicamycin or thapsigargin, but observed a dose- and time-dependent 
reduction in overall Aβ42 and Aβ40 levels. P-tau/T-tau ratio was decreased in PS1-∆E9, 
but not wild type neurons in response to both tunicamycin and thapsigargin at 2 days. 
However, after 5 days of treatment we observed reduced P-tau/T-tau ratio in response to 
tunicamycin only in wild type and PS1-∆E9 neurons. The results presented in this study 
show that the PS1-∆E9 mutation sensitizes and confers resistance to neurons in response 
to different ER stressors, and suggest that ER stress may rescue AD phenotypes. 
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INTRODUCTION 
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Alzheimer’s Disease 
Alzheimer’s Disease (AD) is the most common cause of dementia and is a fatal, 
progressive neurodegenerative disease (Barnes and Yaffe, 2011). It is characterized by 
abnormal accumulation of misfolded proteins in the form of amyloid plaques or 
neurofibrillary tangles (Shepherd et al., 2009; Taylor et al., 2002). There are two forms 
of AD: sporadic AD (SAD) and familial AD (FAD). FAD occurs in patients as young as 
40 or 50 years of age, and makes up just 1-5% of all AD cases(Alzheimer’s Association; 
Strobel). SAD is the most common form of Alzheimer’s and typically occurs in adults 
over 65 years old; 95-99% of all AD cases are of sporadic origin. Three primary genes 
have been identified as causative of FAD: amyloid precursor protein (APP), presenilin 1 
(PSEN1), and presenilin 2 (PSEN2) (Bekris et al., 2010). PSEN1 codes the presenilin-1 
(PS1) protein: one of four core proteins that make up the gamma (γ) secretase complex 
which cleaves APP, a type 1 transmembrane protein, to generate amyloid-beta (Aβ) 
protein fragments (Haapasalo and Kovacs, 2011). Aβ peptide fragments that are 40- and 
42-amino acids long are more involved in AD progression, with the latter being more 
prone to aggregation and forming the characteristic amyloid plaques (Taylor et al., 2002). 
 Another key protein in AD pathogenesis is the microtubule-associated protein 
(MAP) tau. Tau protein is the major component of MAPs in axons and is critical for 
stabilizing microtubules and mediating axonal transport (Rodríguez-Martín et al., 2013; 
Weingarten et al., 1975). Under pathological conditions tau aggregates into paired helical 
fragments (PHFs) and neurofibrillary tangles (NFTs) (Kosik et al., 1986). 
Hyperphosphorylation of tau (pTau) has been suggested to increase aggregation and 
contribute to disease progression (Grundke-Iqbal et al., 1986).  
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Endoplasmic Reticulum Stress and the Unfolded Protein Response in Alzheimer’s 
disease 
The ER functions as the primary site for protein synthesis, folding, and calcium 
storage. Disruptions in ER calcium levels, chaperone protein function, and ER-associated 
degradation (ERAD) pathways can result in a condition called ER stress (Cornejo and 
Hetz, 2013). To relieve this stress, the ER initiates a series of signal transduction 
cascades to reduce translation, increase transcription of chaperone proteins, and target 
misfolded proteins for degradation (Cornejo and Hetz, 2013; Pereira, 2013). These signal 
cascades and cellular functions are collectively called the unfolded protein response 
(UPR) (Cornejo and Hetz, 2013; Forman et al., 2003; Merksamer and Papa, 2010; 
Naidoo and Brown, 2012; Pereira, 2013; Walter and Ron, 2011). Chronic or irreparable 
ER stress will result in activation of pro-apoptotic factors in an effort to eliminate 
damaged cells (Jäger et al., 2012; Katayama et al., 2004; Tabas and Ron, 2011). 
There are three specialized ER stress-sensing molecules involved in the human 
UPR pathway: Inositol-required enzyme 1 α (IRE1α), protein kinase RNA-like ER kinase 
(PERK), and activating transcription factor 6 (ATF6). Under normal conditions, the three 
sensors are inactivated due to binding of the ER chaperone binding immunoglobulin 
protein (BiP/glucose-related protein 78—GRP78), which is encoded by the HSPA5 
gene.(Pereira, 2013). Inducing ER stress causes BiP to be released from these sensors, 
activating them (Figure 1) (Pereira, 2013; Plácido et al., 2014). BiP is a member of the 
heat shock protein 70 (HSP70) family and is involved in several ER functions, such as 
folding of newly synthesized proteins and binding to misfolded proteins to prevent 
protein aggregation (Gething, 1999).  
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Activating IRE1α leads to specific degradation of mRNAs that encode proteins 
with abnormal folding and catalyzes the splicing of a 26 base-pair intron from mRNA 
encoding the transcription factor X-box binding protein 1 (XBP1). This causes a reading 
frame shift, resulting in the expression of the spliced form which is a potent transcription 
activator that upregulates genes encoding proteins that enhance protein folding and 
targets misfolded proteins for degradation (Cornejo and Hetz, 2013; Lin et al., 2008; 
Pereira, 2013). IRE1α also activates downstream modulators that induce cellular 
apoptosis (Lin et al., 2008). 
PERK activation attenuates protein synthesis by phosphorylating eukaryotic 
translation initiator factor 2α (eIF2α). Decreasing protein synthesis is a mechanism to 
reduce protein load in the ER to help alleviate ER stress. However, phosphorylating 
eIF2α paradoxically increases translation of activating transcription factor 4 (ATF4). 
ATF4 activation causes increased translation of ER chaperones in an effort to alleviate 
ER stress; ATF4 also upregulates translation of the transcription factor CCAAT/enhancer 
binding protein homologous protein (CHOP) that promotes apoptosis (Lin et al., 2008). 
Inducing PERK in vitro has been shown to attenuate Aβ-mediated ER stress (Lee et al., 
2010). 
Activation of ATF6 causes its translocation to the Golgi, where it is cleaved by 
site-1 protease and site-2 protease (Cornejo and Hetz, 2013; Lin et al., 2008). The active 
fragment is released into the cytosol where it is targeted the nucleus where it activates 
transcription of ER chaperones, ERAD-related genes, and genes for organelle biogenesis 
(Pereira, 2013). 
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 As mentioned earlier, chronic or irreparable ER stress activates apoptosis. One 
mediator is the activation of CHOP, which downregulates anti-apoptotic genes and 
upregulates pro-apoptotic genes leading to cell death (Jäger et al., 2012; Tabas and Ron, 
2011). Previous studies have shown evidence of increased levels of ER stress markers in 
postmortem primary brain tissue of AD patients (Hoozemans et al., 2005, 2009), again 
suggesting that Aβ and ER stress are linked. 
The relationship between presenilin and ER stress in Alzheimer’s disease is unclear 
 One hypothesis for the cause of AD is the amyloid cascade hypothesis, which is 
based on APP processing. APP can be cleaved through two pathways: the first involves 
sequential cleavage of APP via α-secretase and γ-secretase to generate α C-terminal 
fragments (CTFs) and a p53 fragment; this pathway is generally considered the non-
amyloidogenic pathway. The second, which is called the amyloidogenic pathway, 
involves sequential cleavage of APP by β-secretase and γ-secretase, resulting in the 
production of Aβ fragments of various sizes, the relevant ones being 40-42 amino acids 
in length (Hardy and Allsop, 1991; Hardy and Higgins, 1992). Over 100 pathogenic PS1 
mutations have been characterized in FAD, and these mutations account for the largest 
proportion of FAD causes; these mutations typically alter the ratio of Aβ42 to Aβ40 in 
the cell (Kelleher and Shen, 2017; Sun et al., 2017). Altering the ratio of Aβ42 to Aβ40 
has been hypothesized as a causative agent for FAD (Scheuner et al., 1996). 
Additionally, introducing exogenous Aβ42 to in vitro cultures was shown to induce ER 
stress and activate the UPR by observing increases in BiP and CHOP mRNA levels (Lee 
et al., 2010).  
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There has been continual debate regarding FAD PS1 mutations and whether they 
disrupt the ability of neurons to activate the UPR. Niwa et al., 1999 used HeLa cells to 
demonstrate that PS1 is required for proper IRE1α localization upon activation of the 
UPR. They also showed that knocking out PS1 in cells compromises UPR function. 
Katayama et al., 1999 also showed a connection between PS1 and IRE1α function. In 
their experiments, they discovered that FAD PS1 mutations reduce the efficacy of the 
UPR signaling pathway in neuroblastoma cells transfected with wild type PS1 and FAD-
related PS1 mutations. The same authors found similar results in a second paper as well 
(Katayama et al., 2001). However, other groups found different results, specifically that 
fibroblasts obtained from patients bearing a PS1 mutation have a normal UPR (Piccini et 
al., 2004a), or that upregulation of BiP and CHOP mRNA in PS1 knockout mouse 
embryonic fibroblasts and neuroblastoma cells is independent of presenilin expression 
(Sato et al., 2000). 
Involvement of ER stress in tau phosphorylation in Alzheimer’s disease 
The other key protein involved in AD, tau, is a microtubule-associated protein 
that promotes the stability of microtubules (Weingarten et al., 1975). Under AD 
conditions, tau phosphorylation increases, compromising its function resulting in toxic 
tau aggregation and breakdown of microtubules (Alonso et al., 1994). 
Hyperphosphorylation of tau is related to the activity of kinases such as glycogen 
synthase kinase -3 beta (GSK-3β), which has been shown to be activated in response to 
ER stress caused by thapsigargin, an inhibitor of ER Ca2+-ATPase (Song et al., 2002). 
GSK-3β was also shown to be activated in response to Aβ oligomer-induced ER Ca2+ 
release, resulting in increases in tau phosphorylation (Resende et al., 2008). Other studies 
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describing mutations in the PSEN1 gene have shown associations between different 
PSEN1 mutations and changing tau and pTau levels (Dong et al., 2017; Luedecke et al., 
2014).  
Using hiPSC-derived NSCs and neurons to study ER stress in Alzheimer’s disease 
Mouse models overexpressing APP and/or PSEN1 genes implicated in FAD are 
powerful tools that allow researchers to study the impacts of Aβ aggregation on memory 
and behavior that cannot be seen in vitro. Although many such models develop relevant 
AD-related Aβ pathology such as age-dependent cognitive impairment and memory 
deficits (Janus et al., 2000), challenges have arisen when attempting to determine the 
relative contributions of Aβ, APP, and other APP metabolites to AD pathology seen in 
mouse models. Furthermore, many of these mouse models that overexpress APP and/or 
PSEN1 do not exhibit symptoms of other pathological features of AD, including neuronal 
death and the presence and accumulation of neurofibrillary tangles (Drummond and 
Wisniewski, 2017). The presence of APP and/or PSEN1 overexpression in mice does not 
guarantee AD-associated neuropathology either (Drummond and Wisniewski, 2017; Kim 
et al., 2013). While transgenic mice have been generated to express human tau, tangle 
formation is not observed unless the mice contain mutations associated with 
frontotemporal lobar degeneration (FTLD) (Drummond and Wisniewski, 2017). These 
pose a different limitation in that the FTLD-related mutations are not typically seen in 
AD pathology in humans.  
Using human tissue to study AD bypasses many of the issues that result from 
species differences. However, it poses other challenges, such as the lack of available, 
quality post-mortem tissue. The development of human induced pluripotent cells 
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(hiPSCs) (Takahashi et al., 2007) have circumvented many of the pervious limitations in 
using human tissue, such as using non-neuronal cell lines transfected or transduced with 
APP or PSEN1 mutations (Katayama et al., 1999, 2004; Niwa et al., 1999). 
In order to study the effects of a representative FAD mutation on cell viability, Aβ 
42 levels, and hyperphosphorylated tau levels in response to ER stress, we used isogenic 
human induced pluripotent stem cell (hiPSC)-derived neural stem cells (NSCs) and 
neurons reprogrammed from fibroblasts from a healthy human donor (Woodruff et al., 
2013). The cell lines had their genomes engineered using TAL effector nuclease 
(TALENs) technology to introduce an allelic series of mutations in the PSEN1 gene, 
referred to as the PS1-ΔE9 (PS1-ΔE9). The specific mutation is caused by a deletion of 
exon 9 in the PSEN1 gene, and has been shown to generate an AD phenotype as seen by 
increases in Aβ42/Aβ40 ratio through increasing Aβ42 and decreasing Aβ42 levels 
(Woodruff et al., 2013). The PS1-ΔE9 mutation present in our cell lines was shown to act 
also as a gain of function mutation, resulting in a “super leaky” channel, leading to 
increased cytosolic Ca2+ levels and decreased ER Ca2+ levels (Chaves R. S., 
unpublished). Preliminary results from our lab also showed that chemically inducing ER 
stress in PS1-ΔE9 NSCs and neurons resulted in different levels of induction of well-
known ER stress genes (e.g., BiP and XBP1; Almenar and Roberts, unpublished data), 
which suggests that PS1-ΔE9 mutants may be more sensitive to ER stress. 
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RESULTS 
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PS1-∆E9 NSCs may be more sensitive to ER stress-induced cell death 
In order to mimic conditions of chronic ER stress and to test its effects on cellular 
viability, we treated control human induced pluripotent stem cell (hiPSC) -derived neural 
stem cells (NSCs) with varying concentrations of tunicamycin, an N-glycosylation 
inhibitor, which has been shown to induce ER stress (Dorner et al., 1990). Previous 
studies typically used tunicamycin concentrations ranging between 1-10 µg/ml for 
anywhere from a few hours (Oslowski and Urano, 2011; Song et al., 2002) to between 24 
and 48 hours (Oslowski and Urano, 2011; Takahashi et al., 2009). However, these studies 
used non-neuronal cell lines, and so to measure the effects of tunicamycin in our system, 
we treated control NSCs in a dilution series for 24 and 48hrs. No cell death was observed 
24hrs after treatment with tunicamycin (Figure 2A), however after 48hrs cell death was 
observed in a dose-dependent manner with increasing tunicamycin concentration (Figure 
2B). We used staurosporine, a compound that induces apoptosis, as a positive control for 
cell death and observed a dose-dependent decrease in NSC viability at both 24 and 48hrs 
post-treatment (Figure 2C-D). 
Next, to study how the PS1-∆E9 mutation affects cellular viability in response to 
induced ER stress, we treated wild-type (WT/WT), heterozygous mutant (WT/∆E9), and 
homozygous mutant (∆E9/∆E9) NSCs with varying doses of tunicamycin for 24 or 48hrs 
(Figure 3). We observed that both the wild-type NSCs—which do not have the PS1-∆E9 
mutation and should behave similarly to the control NSCs from Figure 2— and the 
WT/∆E9 NSCs showed no significant decrease in cell viability 24hrs post-treatment 
(Figure 3A; left and center). However, cell viability was significantly, albeit marginally, 
decreased in the ∆E9/∆E9 NSCs (Figure 3A; right). The differences in viability between 
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genotypes in response to tunicamycin was lost after 48hrs, however, with all cells 
showing up to 50% reduction in viability (Figure 3B; left, center, right). Our data 
suggests that the PS1-∆E9 mutation sensitizes NSCs to ER-stress, increasing their 
susceptibility to ER stress-induced cell death. 
Control neurons do not die after ER stress is induced, but still upregulate ER stress 
genes 
Next, we asked whether we would observe the same effects in NSC-differentiated 
neurons as we saw in NSCs. We differentiated the above control NSCs for three weeks 
before replating them at uniform density onto a 96-well plate. After waiting two weeks to 
let the replated neurons recover, we treated neurons with varying doses of tunicamycin 
for 48hrs, and observed no significant differences in neuron viability, even at a higher 
concentration of tunicamycin than what was used in NSCs (Figure 4A). However, we did 
see a downward trend in neuron viability as tunicamycin concentration increased. 
Staurosporine was used as a positive control for cell death again, and we observed a dose-
dependent decrease in cell viability (Figure 4B). 
Because no neuron death was observed, we asked whether the neurons were 
responding to tunicamycin and generating an ER stress response. We measured changes 
in mRNA levels of two different ER stress genes: BiP and spliced XBP1. As stated 
earlier, under ER stress conditions, BiP dissociates from IRE1α, which activates it 
causing it to splice a 26 base-pair intron from XBP1 mRNA to generate its spliced form 
(Figure 1), which is a potent transcription factor that activates many downstream UPR 
pathways. BiP, being a chaperone protein, will bind to misfolded proteins and is 
sequestered into complexes with those proteins. The eventual decrease of free BiP may 
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be the signal that induces increased transcription of ER stress genes (Gething, 1999). 
After the neurons were treated with tunicamycin for 48hrs, RT-qPCR was performed to 
measure the relative levels of BiP and spliced XBP1 mRNA. We observed that BiP 
mRNA increased nearly 20-fold (Figure 5A), and spliced XBP1 mRNA increased by 10- 
to 20-fold (Figure 5B) with tunicamycin treatment. Taken together, these results show 
that neurons can initiate the UPR after ER stress is induced by tunicamycin, without 
inducing cell death. 
PS1-∆E9 neurons differ in their response to induced ER stress compared to controls 
Next, we wanted to determine whether neuron viability is reduced by ER stress in 
neurons expressing the PS1-∆E9 mutation. To do so, we treated one wild-type control 
and two independently-generated PS1-ΔE9 mutant neuronal lines for two days or five 
days with various doses of tunicamycin and measured cellular viability and changes in 
expression of three ER stress genes: BiP, spliced XBP1, and CHOP. We found that wild-
type neurons showed no significant decrease in viability (Figure 6A, left) and significant 
reductions in viability in both PS1-∆E9 mutants after two days of tunicamycin treatment. 
After five days of tunicamycin treatment these differences were lost, and we saw dose-
dependent decreases in viability in wild-type and PS1-∆E9 neurons (Figure 6B). To rule 
out the possibility that our vehicle treatment was negatively affecting our cells, we mock 
treated our neurons with only media or with just the vehicle for two and five days. We 
observed no difference in viability with the vehicle compared to the untreated condition 
(Figure 6A, untreated; 6C). One hypothesis we had for the different responses to cell 
viability after treating the cells for two days was that the PS1-ΔE9 mutants may have 
lower basal viability than the wild-type control. To address this, we counted the cells 
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using trypan blue on an automated cell counter every time the cells were replated and 
recorded the percent of viable cells present. We found no significant difference in the 
basal viability across all three lines (Figure 6D).  
After observing a slight difference in viability between PS1-∆E9 neurons and 
wild-type neurons after tunicamycin treatment, we asked whether we would observe the 
same results by using a different ER stress inducer with a different mechanism of action. 
We chose to use thapsigargin, which induces ER stress by inhibiting SERCA and results 
in elevated cytosolic Ca2+ levels. We treated neurons with thapsigargin for two or five 
days before measuring cell viability and saw no decrease in cell viability in wild-type 
neurons (Figure 7A, left) and only slight reduction of cell viability in one of the PS1-∆E9 
mutants (Figure 7A, center) after two days of thapsigargin treatment. Interestingly, after 
five days the thapsigargin induced approximately 25% decrease in viability in wild-type 
neurons (Figure 7B; left), whereas it had little to no effect on the PS1-∆E9 neurons 
(Figure 7B; center and right). 
To address our initial hypothesis that PS1-ΔE9 neurons would have a 
constitutively activated UPR, we also measured basal expression of ER stress-related 
genes after treatment with only the drug vehicle: DMSO. We found that control and PS1-
ΔE9 neurons have similar basal expression of BiP (Figure 8A; left) but have different 
levels of spliced XBP1 and CHOP (Figure 8A; center and right). Upon treatment with 
tunicamycin for two days we found that the three ER stress genes showed elevated 
expression levels compared to the vehicle treatment (Figure 8B). However, wild-type and 
PS1-∆E9 neurons exhibited similarly elevated levels of BiP and spliced XBP1 expression 
when treated with tunicamycin (Figure 8B; left, center), except the ∆E9/∆E9-1 mutant 
14 
 
 
 
line showed significantly elevated levels of CHOP expression compared to both wild-
type and the ∆E9/∆E9-2 mutant, which was not significantly different compared to wild-
type (Figure 8B; right). When we treated the neurons with thapsigargin, wild-type 
neurons showed a nearly three-fold increase in BiP expression compared to both PS1-
∆E9 mutants (Figure 8C; left); spliced XBP1 was significantly different between wild-
type and only one of the PS1-∆E9 neurons (Figure 8C, middle). Additionally, CHOP 
expression was higher in wild-type neurons compared to both PS1-∆E9 mutants (Figure 
8C; right). Our results here suggest the PS1-∆E9 mutation may sensitize neurons to 
tunicamycin-induced ER stress while conferring resistance to thapsigargin-induced ER 
stress. Additionally, our results show no consistent elevation or suppression of expression 
of three ER stress genes, suggesting that the PS1-∆E9 does not alter the neurons’ ability 
to activate the ER stress response after insult. 
Effects of induced ER stress on secreted Aβ42 and Aβ40 levels  
 Previous studies on Aβ and ER stress have shown connections between the two, 
with evidence for oligomeric forms of Aβ42 activating the ER stress response (Lee et al., 
2010), along with Aβ accumulation associated with inducing ER stress (as reviewed by 
Placido et al., 2014). The PS1-∆E9 mutation was previously shown to increase the 
Aβ42/40 ratio by increasing Aβ42 and decreasing Aβ40 (Woodruff et al., 2013). Because 
the primary function of the ER stress response and the UPR is to alleviate stress from 
misfolded or accumulated proteins, we asked whether inducing ER stress would increase 
or decrease the elevated Aβ42/Aβ40 ratio observed in the PS1-∆E9 neurons. We treated 
replated neurons with varying doses of tunicamycin for two or five days, and collected 
the media to measure soluble Aβ42 and Aβ40. We observed no significant change in the 
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Aβ42/Aβ40 ratio after treating the wild-type and PS1-∆E9 mutants with tunicamycin for 
two days (Figure 9A). When looking at Aβ42 and Aβ40 levels individually, we noticed 
that both Aβ42 and Aβ40 exhibited a downward trend as tunicamycin dose increased 
(Figure 9B, C) across the three neuron lines. Interestingly, we saw significant decreases 
in only Aβ40 levels with 10 µM tunicamycin treatment in the WT/WT line (Figure 9C, 
left), along with significant decreases in Aβ42 and Aβ40 levels in only one PS1-∆E9 
mutant (Figure 9B, C; center), but not the other. After treating wild-type and PS1-∆E9 
neurons with tunicamycin for five days we observed no changes to the Aβ42/Aβ40 ratio 
in wild-type or PS1-∆E9 neurons (Figure 10A). When we looked at Aβ42 and Aβ40 
levels, we saw very significant decreases in Aβ42 and Aβ40 in the wild-type and both 
PS1-∆E9 neurons (Figure 10B, C). 
Next we wanted to see if we would observe similar effects on Aβ42, Aβ40, or the 
Aβ42/Aβ40 ratio when we treated neurons with thapsigargin for two or five days. Here 
we also observed no significant change in the Aβ42/Aβ40 ratio in wild-type or PS1-∆E9 
mutants (Figure 11A). When looking at Aβ42 and Aβ40 levels individually, however, we 
saw no significant changes in the levels of either Aβ42 and Aβ40 (Figure 11B, C). We 
did observe a slight downward trend in Aβ42 and Aβ40 levels in the WT/WT and 
∆E9/∆E9-1 lines, but not in the ∆E9/∆E9-2 line. After five days of thapsigargin 
treatment, we observed no change in the Aβ42/Aβ40 ratio (Figure 12A). When looking at 
Aβ42 and Aβ40 individually, however, we saw slight decreases in Aβ42 and Aβ40 in the 
wild-type line (Figure 12B, C; left) and inconsistent changes in the PS1-∆E9 mutants 
(Figure 12B, C; center, right). Overall these results suggest that ER stress, induced by 
tunicamycin or thapsigargin for two days, does not increase or decrease the Aβ42/Aβ40 
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ratio in wild-type or PS1-∆E9 mutant neurons. After five days, however, tunicamycin 
significantly reduces levels of Aβ42 and Aβ40 in wild-type and PS1-∆E9 neurons 
without changing the Aβ42/Aβ40 ratio, while thapsigargin appears to primarily affects 
wild-type neurons. Our results suggest that inducing ER stress in neurons decreases 
overall Aβ42 and Aβ40 without affecting Aβ42/Aβ40, regardless of genotype. 
Effects of induced ER stress on tau phosphorylation  
 Next we wanted to determine whether ER stress can affect the P-tau/T-tau ratio. 
Previous studies have shown involvement of ER stress in hyperphosphorylation of tau 
(Grundke-Iqbal et al., 1986; Hoozemans et al., 2009), which is the primary protein that 
forms the neurofibrillary tangles seen in AD. We treated wild-type and PS1-∆E9 mutant 
neurons with 1 µM of tunicamycin and 1 µM of thapsigargin for two or five days before 
measuring total tau (T-tau) and phosphorylated tau (P-tau) in whole cell lysate. We 
observed no change in the P-tau/T-tau ratio in wild-type neurons after two-day treatment 
with tunicamycin or thapsigargin (Figure 13A, left). This was due to no observed changes 
in P-tau (Figure 13B, left) or T-tau (Figure 13C, left).  When the PS1-∆E9 mutants were 
treated with 1 µM tunicamycin or 1 µM thapsigargin, we observed approximately a 25% 
decrease in the P-tau/T-tau ratio compared to the vehicle treatment (Figure 13A; center, 
right). The reason for this decrease, however, differed between the two mutant lines. We 
observed a significant decrease in P-tau in the ∆E9/∆E9-1 neurons (Figure 13B, center) 
after thapsigargin treatment, and a slight decrease after tunicamycin treatment (although 
not significant). This was accompanied by a slight increase in T-tau after tunicamycin 
treatment, but no change in T-tau after thapsigargin treatment (Figure 13C, center). In the 
∆E9/∆E9-2 neurons, we observed a slight increase in P-tau after treatment with 1 µM 
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tunicamycin (Figure 13B, right) along with an almost 50% increase in T-tau after 
tunicamycin treatment (Figure 13C, right). We observed that thapsigargin-induced ER 
stress did not change P-tau levels in the ∆E9/∆E9-2 neurons (Figure 13B, right), but it 
may have subtly increased T-tau levels (Figure 14C, right), leading to an overall decrease 
in the P-tau/T-tau ratio. 
 After we treated wild-type and the PS1-∆E9 neurons with tunicamycin and 
thapsigargin for five days, we observed greatly reduced P-tau/T-tau ratios in the wild-
type and both PS1-∆E9 mutants with tunicamycin treatment, but only a significant 
decrease in P-tau/T-tau ratio with thapsigargin treatment in the wild-type line (Figure 
14A). Interestingly, the P-tau/T-tau ratio dropped to approximately the same value in all 
three cell lines treated with tunicamycin (~0.005). The reduction in the P-tau/T-tau ratio 
after tunicamycin treatment was primarily due to decreases in P-tau (Figure 14B) whereas 
T-tau was not significantly affected in the wild-type or PS1-∆E9 neurons (Figure 14C). 
These results suggest that long-term induction of ER stress with tunicamycin, not 
thapsigargin, reduces the P-tau/T-tau ratio by decreasing P-tau levels. 
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Figure 1. The Unfolded Protein Response. Disruptions in endoplasmic reticulum (ER) 
homeostasis results in activation of signal cascades associated with the ER stress 
sensors: protein kinase RNA-like ER kinase (PERK), inositol-requiring enzyme-1alpha 
(IRE1α), and activating transcription factor 6 (ATF6). Under non-stressed conditions, 
these three sensors are inactivated through binding with BiP. However, accumulation of 
misfolded proteins causes BiP to dissociate from the three sensors, which become 
activated. Active PERK phosphorylates eIF2α which attenuates general translation, 
resulting in overall decreased protein load in the cell. eIF2α paradoxically increases 
translation of activating transcription factor 4 (ATF4), which induces transcription of 
ER chaperones. Activated IRE1α splices a 26-base pair segment of XBP1 mRNA; this 
spliced form induces transcription of ER chaperones and ER-associated protein 
degradation pathway genes. Activated ATF6 migrates to the Golgi apparatus, where it is 
cleaved by site-1 and site-2 proteases. This cleaved form (ATF6p50) migrates to the 
nucleus where it upregulates UPR elements. Under conditions of chronic or irreparable 
ER stress, all three pathways are capable of inducing ER stress-mediated apoptosis by 
upregulating pro-apoptotic genes such as C/EBP-homologous protein (CHOP). 
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Figure 2. Tunicamycin induces death in a dose- and time-dependent manner in 
control NSCs. (A-B) Control NSCs were treated with tunicamycin (Tn) at various 
doses for one or two days. (C-D) Control NSCs were treated with staurosporine (STS) 
at various doses for one or two days. Bars represent mean of three independent 
experiments. Error bars represent SEM of three biological replicates per experiment. 
****p < 0.0001 by One-way ANOVA. 
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Figure 3. PS1-ΔE9 NSCs differ in viability in response to tunicamycin-induced ER 
stress. NSCs were treated with the drug vehicle, tunicamycin at varying doses, or mock 
treated (untreated), for one (A) or two (B) days. Cell viability is expressed as percent 
viable cells compared to vehicle. Bars represent mean of three independent experiments. 
Error bars represent SEM of three biological replicates per experiment. ****p < 0.0001 
by One-way ANOVA. 
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Figure 4. Control neurons are more resilient to tunicamycin-induced ER stress than 
NSCs. (A) Neurons were treated with tunicamycin (Tn) at varying doses for two days. 
Bars represent mean of three independent experiments. Error bars represent SEM of three 
biological replicates per experiment. (B) Control neurons were treated with staurosporine 
(STS) at varying doses for two days to serve as a positive control for cell death. Bars 
represent mean of three independent experiments. Error bars represent SEM of three 
biological replicates per experiment. *p<0.05, **p<0.01, ***p<0.001, ****p < 0.0001 by 
One-way ANOVA. 
 
Figure 5. Tunicamycin induces elevated transcription of ER stress genes without 
reducing cellular viability. Control neurons were treated with varying concentrations of 
tunicamycin (Tn) for two days. RT-qPCR was done to measure the relative fold change 
in gene expression. Bars represent the mean from three independent experiments. Error 
bars represent SEM of three technical replicates per condition. *p<0.05, **p<0.01, 
***p<0.001, ****p < 0.0001 by One-way ANOVA. 
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Figure 4. PS1-∆E9 neurons are marginally more sensitive to ER stress-induced 
death. (A) Neuron viability measured as percentage of vehicle after treatment with 
varying concentrations (µM) of tunicamycin (Tn) for two days. Bars represent 
measurements from three independent experiments per condition. Error bars represent 
SEM from 9 biological replicates per condition. (B) Neuron viability measured as 
percentage of vehicle after treatment with varying concentrations (µM) of tunicamycin 
(Tn) for five days. Bars represent measurements from three independent experiments 
per condition. Error bars represent SEM from 9 biological replicates per condition. (C) 
Neuron viability measured as percentage of vehicle after mock treatment (untreated) or 
vehicle only treatment. Bars represent measurements from one experiment per line. 
Error bars represent SEM from three biological replicates per condition. (D) Basal 
neuron viability measured as percent survival after trypan blue count prior to replating. 
Scatter dot plot represents median percentage of viable cells from three independent 
experiments. (A-D) Statistics performed using One-way ANOVA. *p<0.05, **p<0.01, 
***p<0.001, ****p < 0.0001 
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Figure 5. PS1-∆E9 neurons are less sensitive to thapsigargin-induced ER stress cell 
death. (A) Neuron viability measured as percentage of vehicle after treatment with 
varying concentrations of thapsigargin (Tg) for two days. Bars represent measurements 
from three independent experiments per condition. Error bars represent SEM from 9 
biological replicates per condition. Statistics performed using One-way ANOVA. Dashed 
line = 100% viability. (B) Neuron viability measured as percentage of vehicle after 
treatment with varying concentrations of thapsigargin (Tg) for five days. Bars represent 
measurements from three independent experiments per condition. Error bars represent 
SEM from 9 biological replicates per condition. Statistics performed using One-way 
ANOVA. Dashed line = 100% viability. *p<0.05, **p<0.01, ***p<0.001, ****p < 
0.0001 
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Figure 6. PS1-∆E9 neurons express different levels of ER stress genes compared 
to wild-type neurons. Wild-type or PS1-∆E9 neurons were treated with 1 µM of 
either tunicamycin (Tn) or thapsigargin (Tg) for two days RT-qPCR was performed 
to measure the relative fold change in mRNA. Bars represent the mean fold change of 
each gene normalized to three house-keeping genes: RPL17, RPL13A, and TBP, and 
then normalized to vehicle = 1 (not shown) from two independent experiments. Error 
bars represent SEM from three technical replicates per treatment condition. *p<0.05, 
**p<0.01, ***p<0.001, ****p < 0.0001 by One-way ANOVA 
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Figure 7. Tunicamycin-induced ER stress does not change the Aβ42/Aβ40 ratio. 
Secreted Aβ42/Aβ40 ratio (A), Aβ42 (B), and Aβ40 (C) were measured from wild-type 
and PS1-∆E9 mutants treated with increasing concentrations of tunicamycin (Tn) for two 
days. Bars represent measurements from one experiment normalized to total protein 
concentration. Error bars represent SEM from three biological replicates per experiment. 
Additional experiments were repeated and showed similar results, but could not 
normalize to total protein (data not shown). Statistics performed via One-way ANOVA. 
*p < 0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
  
26 
 
 
 
 
Figure 8. Extended treatment of neurons with tunicamycin does not affect 
Aβ42/Aβ40 ratio, but does decrease both Aβ42 and Aβ40. Secreted Aβ42/Aβ40 ratio 
(A), Aβ42 (B), and Aβ40 (C) were measured from wild-type and PS1-∆E9 mutants 
treated with increasing concentrations of tunicamycin (Tn) for five days. Bars represent 
measurements from one experiment normalized to total protein concentration. Error bars 
represent SEM from three biological replicates per experiment. Additional experiments 
were repeated and showed similar results, but could not normalize to total protein (data 
not shown). Statistics performed via One-way ANOVA. *p<0.05, **p<0.01, ***p<0.001, 
****p < 0.0001. 
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Figure 9. Thapsigargin-induced ER stress does not change the Aβ42/Aβ40 ratio. 
Secreted Aβ42/Aβ40 ratio (A), Aβ42 (B), and Aβ40 (C) were measured from wild-type 
and PS1-∆E9 mutants treated with increasing concentrations of thapsigargin (Tg) for two 
days. Bars represent measurements from two independent experiments and normalized to 
total protein concentration. Error bars represent SEM from three biological replicates per 
experiment. Additional experiments were repeated and showed similar results, but could 
not normalize to total protein (data not shown). Statistics performed via One-way 
ANOVA. 
 
 
28 
 
 
 
 
Figure 10. Extended treatment of neurons with thapsigargin does not affect the 
Aβ42/Aβ40 ratio in wild-type or PS1-∆E9 neurons, but decreases Aβ42 and Aβ40 in 
wild-type neurons. Secreted Aβ42/Aβ40 ratio (A), Aβ42 (B), and Aβ40 (C) were 
measured from wild-type and PS1-∆E9 mutants treated with increasing concentrations of 
thapsigargin (Tg) for five days. Bars represent measurements from one experiment 
normalized to total protein concentration. Error bars represent SEM from three biological 
replicates per experiment. Additional experiments were repeated and showed similar 
results, but could not normalize to total protein (data not shown). No value shown for 1 
µM thapsigargin in WT/WT due to an error in the measurements. Statistics performed via 
One-way ANOVA. *p < 0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
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Figure 11. ER stress induced for two days reduces p-tau/t-tau ratio in PS1-∆E9 
neurons. Total tau (T-tau) and phosphorylated tau (P-tau) were measured in wild-type 
and PS1-∆E9 neurons after treatment with 1 µM tunicamycin (Tn) or 1 µM thapsigargin 
(Tg) for two days. Bars represent mean of one experiment. Error bars represent SEM 
from three biological replicates. *p < 0.05, **p<0.01, ***p<0.001, ****p<0.0001 by 
One-way ANOVA. 
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Figure 12. Prolonged induction of ER stress by tunicamycin reduces P-tau/T-tau 
ratio by decreasing P-tau. Total tau (T-tau) and phosphorylated tau (P-tau) were 
measured in wild-type and PS1-∆E9 neurons after treatment with 1 µM tunicamycin (Tn) 
or 1 µM thapsigargin (Tg) for five days. Bars represent mean of one experiment. Error 
bars represent SEM from three biological replicates. *p < 0.05, **p<0.01, ***p<0.001, 
****p<0.0001 by One-way ANOVA. 
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In the present study, we have demonstrated that NSCs are more sensitive to ER 
stress-induced cell death than neurons, that an FAD PS1-∆E9 mutation in NSCs and 
neurons alters cellular viability in response to ER stress, and the same mutation in 
neurons changes levels of ER stress gene expression before and after ER stress is 
induced. Additionally, we showed that inducing ER stress with tunicamycin or 
thapsigargin does not affect the Aβ42/Aβ42 ratio in human neurons. This is due to 
reductions in both Aβ42 and Aβ40 levels, and is independent of the PS1-∆E9 mutation. 
Our results also show that tunicamycin- and thapsigargin-induced ER stress reduces the 
P-tau/T-tau ratio in wild type and PS1-∆E9 neurons by reducing P-tau levels. 
Previous experiments studying the relationship between ER stress and presenilin 
mutations, Aβ, or P-tau have typically used non-neuronal cell lines and mouse models 
(Dorner et al., 1990; Drummond and Wisniewski, 2017; Gerakis et al., 2016; Takahashi 
et al., 2009). However, Alzheimer’s is a neurodegenerative disease where Aβ plaques, 
neurofibrillary tangles, and cell death all occur in neurons, with astrocytes, microglia, and 
other neural cells implicated in disease progression as well. Thus, it is important to use 
the relevant human cell type in studying AD to be able to make accurate conclusions. 
Prior research looking at the relationship between PS1 mutations and ER stress has 
yielded controversial results, with some researchers claiming that PS1 mutations suppress 
the expression of BiP in response to ER stress (Katayama et al., 1999), or that presenilin 
is required for proper UPR function (Katayama et al., 2001; Niwa et al., 1999; Yasuda et 
al., 2002). However, other groups claim that mutations in PS1 have no effect on the UPR 
(Piccini et al., 2004; Sato et al., 2000). We believe one of the reasons for the controversy 
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surrounding presenilin mutations and ER stress is due to the use of different, non-
neuronal cell types in conjunction with overexpression of the presenilin mutations. 
From our studies using hiPSC-derived neurons and NSCs containing a 
representative FAD PS1-∆E9 mutation, we observed greater sensitivity to tunicamycin in 
NSCs (Figure 3A) and neurons (Figure 6A). This is similar to what Katayama et al., 1999 
observed after using tunicamycin to induce ER stress in neuroblastoma cells transfected 
with the PS1-∆E9 mutation. When we treated wild type and PS1-∆E9 neurons with 
thapsigargin, however, we observed opposite results, where the wild type neurons were 
more sensitive than the PS1-∆E9 neurons were (Figure 7B). This suggests that neurons 
expressing the PS1-∆E9 mutation may not be as sensitive to ER stress induced by 
thapsigargin as the wild type line. The ER is a major calcium storage organelle in 
mammalian cells, and disruptions in ER calcium homeostasis can lead to ER stress. 
Although we did not expect these results, we believe that it fits with what we currently 
know about presenilin proteins and their involvement with ER calcium homeostasis. 
Thapsigargin induces ER stress by inhibiting SERCA, which causes depletion of ER Ca2+ 
and excess Ca2+ buildup in the cytosol. Presenilin proteins themselves act as Ca2+ leak 
channels (Bezprozvanny and Mattson, 2008; Tu et al., 2006; Zhang et al., 2010), and so 
homeostasis is achieved with a balance of SERCA pump activity and PS1 leak activity. 
While most FAD mutations cause a loss of function in ER Ca2+ leak activity, resulting in 
accumulation of Ca2+ in the ER lumen (Tu et al., 2006), the PS1-ΔE9 mutant acts as a 
gain of function mutation in ER Ca2+ leak activity, leading to excessive Ca2+ present in 
the cytosol of the cell and a partially Ca2+-depleted ER (Tu et al., 2006). Preliminary Ca2+ 
experiments performed in the lab have recapitulated these results, confirming that the 
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PS1-ΔE9 mutation present in our neurons results in increased cytosolic Ca2+ levels and 
decreased ER Ca2+ levels (Chaves R. S., unpublished data). This may help to explain our 
viability results in response to thapsigargin treatment: since the PS1-∆E9 mutation results 
in an already Ca2+-depleted ER, thapsigargin has reduced effectiveness because there is 
less Ca2+ present in the ER from the beginning. To further investigate whether the PS1-
∆E9 mutation confers resistance to Ca2+-mediated ER stress, we would use a different 
compound that also depletes ER Ca2+ levels and increases cytosolic Ca2+ levels, such as 
calcium ionophore A23187. 
This hypothesis was further tested when we measured relative levels of gene 
expression after thapsigargin treatment. We observed a greater increase in BiP and 
CHOP expression in the wild type neurons compared to the PS1-∆E9 neurons with 
thapsigargin treatment (Figure 8C; left, right) but not with tunicamycin treatment (Figure 
8B; left, right). When we looked at spliced XBP1 levels, we saw that the levels of spliced 
XBP1 in one mutant were elevated compared to wild type, while the levels of spliced 
XBP1 in the other mutant were not statistically different compared to wild type after 
tunicamycin treatment (Figure 8B, center). Our results contrast with the findings of 
Katayama et al., 1999 because we did not see a suppression of the UPR in neurons 
bearing the PS1-∆E9 mutation after tunicamycin treatment; instead, we saw suppression 
of BiP and CHOP expression in the PS1-∆E9 mutants in response to thapsigargin 
treatment. Our results show that BiP and CHOP expression in response to thapsigargin-
induced ER stress is suppressed by the PS1-∆E9 mutation, whereas XBP1 splicing and 
ER stress gene expression in response to tunicamycin is not consistently altered by the 
presence of the PS1-∆E9 mutation.  
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We hypothesized that the differences observed between the two PS1-∆E9 
mutants—which were generated from an isogenic background— may have arisen from 
variability that occurs during genome-editing of subcloned iPSCs. Woodruff et al., 2013 
had addressed this concern by performing whole-exome sequencing on the TALEN-
modified iPSC lines and the parental iPSC lines. They showed that the wild type control 
line had zero off-target mutations, and the PS1-∆E9 mutants contained one to two unique 
mutations (Woodruff et al., 2013). One of the mutations in just one of the homozygous 
PS1-∆E9 lines was an arginine to histidine substitution in the signal transducer and 
activator of transcription 3 (STAT3) gene, which plays a role in the expression of various 
genes in response to stimuli, and has roles in many processes such as cell growth and 
apoptosis. This may help to explain the differences in viability seen in the two mutant 
lines used in this study. Another possible point of difference between the two PS1-∆E9 
mutants that we cannot rule out is the potential for mutations in the introns of the 
mutants’ genome. Woodruff et al. performed whole-exome sequencing to look for 
protein-coding mutations, introns have numerous functions in transcription initiation and 
termination, and transcription regulation and alternative splicing, to name a few (Carmel 
and Chorev, 2012) that may potentially impact the cells’ response to ER stress.  
Previous studies examining the effects of amyloid-β oligomers on ER stress have 
found that the addition of Aβ42 to culture medium induces ER stress and apoptosis 
(Chafekar et al., 2007; Lee et al., 2010; Multhaup et al., 2015). Additional research 
showed that tunicamycin-induced ER stress lead to elevated Aβ42 production in 
fibroblasts (Piccini et al., 2004)and in retinal ganglion cells (RGC-5) (Liu et al., 2014). 
Because these studies used non-neuronal cells, we wanted to see whether we would 
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observe similar results in human neurons. We initially hypothesized that the treating the 
PS1-∆E9 neurons with tunicamycin would result in even higher Aβ42 levels and thus a 
higher Aβ42/Aβ40 ratio after tunicamycin treatment. This was not the case, however, as 
we observed reductions in both Aβ42 and Aβ40 levels with tunicamycin treatment for 
two and five days. With thapsigargin treatment, we observed slight decreases in Aβ42 
and Aβ40 after five days, primarily in the wild type neurons, and no changes in Aβ42 and 
Aβ40 in the PS1-∆E9 neurons. One study has shown that ER stress induces 
polyubiquitination of APP, targeting it for degradation via the ubiquitin proteasome 
system (Jung et al., 2015). Although Jung et al., 2015 used Chinese hamster ovary cells 
and used a different ER stress inducer, this may help shed light on the reduction of both 
Aβ42 and Aβ40 in response to tunicamycin-induced ER stress in our system. Another 
potential explanation could be due to how tunicamycin induces ER stress. Tunicamycin 
inhibits N-glycosylation of proteins, which has significant ramifications for how APP is 
transported and processed within the cell. However, we cannot rule out the possibility 
that the reduction in Aβ42 and Aβ40 may be due to cell death upon treatment with 
tunicamycin, because we observed almost a 50% reduction in neuron viability with 
tunicamycin treatment for five days.  
 Research on the relationship between ER stress and tau phosphorylation has 
indicated that ER stress increases tau phosphorylation (Resende et al., 2008; Rueli et al., 
2017). We observed the opposite in our neurons, with tunicamycin-induced ER stress 
significantly reducing the P-tau/T-tau ratio in only the PS1-∆E9 mutants after two days, 
and reducting the ratio in wild-type and PS1-∆E9 neurons after five days. These results 
suggest that the P-tau/T-tau ratio in PS1-∆E9 mutants are more sensitive to changes from 
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tunicamycin-induced ER stress. However, because these results come from a single 
experiment, albeit performed with biological triplicates, more experiments are needed to 
strengthen our results. Additionally, although we observed a time-dependent decrease in 
P-tau, we do not know if we would observe a dose-dependent decrease (or increase) in P-
tau since our results only show one concentration of tunicamycin and thapsigargin used. 
Finally, we cannot rule out the possibility that the reduction in P-tau seen after five days 
may have been due to cell death caused by the drug treatments. 
 Overall, our results suggest that the FAD PS1-∆E9 mutation expressed in human 
neurons sensitizes them to tunicamycin-induced ER stress, while at the same time confers 
resistance to thapsigargin-induced ER stress. Our results also show that the PS1-∆E9 
mutation suppresses BiP and CHOP expression in response to thapsigargin, but gene 
expression in response to tunicamycin is not genome-dependent. Contrary to prior 
research in the field, our results suggest that tunicamycin-induced ER stress may decrease 
Aβ42, Aβ40, and P-tau levels, suggesting that either ER stress or inhibiting N-
glycosylation is “rescuing” the AD phenotype. 
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Cell Lines 
 The PS1-ΔE9 NSCs used in the present study were previously generated by 
members of the lab. Briefly, they cultured hiPSCs on an irradiated mouse embryonic 
fibroblast (MEF) feeder layer generated in-house. hiPSC genomes were edited using TAL 
effector nuclease (TALEN) technology to introduce the FAD-associated PSEN1-ΔE9 
mutation. (Woodruff et al., 2013) 
Cell Culture 
NSCs were grown and maintained in Dulbecco’s Modified Eagle 
Medium/Nutrient Mixture F-12 (DMEM/F12; ThermoFisher) supplemented with B-27, 
N-2 (Life Technologies), penicillin-streptomycin (100 U/mL, Life Technologies) and 
fibroblast growth factor (FGF; EMD Millipore, 20 ng/mL). Media was changed every 
other day. When grown to ~90% confluency, NSCs were dissociated with Accutase 
(Innovative Cell Technologies) and expanded onto poly-L-ornithine hydrobromide- 
(PLO, 20 µg/ml) and laminin- (5 µg/mL) coated 10 cm plates and grown to confluency, 
at which point FGF was removed from the media. The medium was changed twice per 
week and the cells were allowed to differentiate for 21 days. After the three-week 
differentiation, neurons were dissociated using Accutase and Accumax (Innovative Cell 
Technologies) and then passed through a 100 µm filter before plating onto PLO/laminin-
coated plates in NSC media containing 0.5 mM dbCAMP (Sigma), 20 ng/µl brain-
derived neurotrophic factor (BDNF; Peprotech), and 20 ng/µl glial cell line-derived 
neurotrophic factor (GDNF; Peprotech). Cultures were incubated at 37°C in a 95% 
air/5% CO2 humidified atmosphere. Cells were then treated with tunicamycin (Sigma), 
thapsigargin (Sigma), MG132 (EMD Millipore), or staurosporine (Sigma). These 
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compounds were solubilized in DMSO to make stock concentrations. 0.01% DMSO was 
used as a vehicle control for studies with these compounds. 
Cell Viability Assay 
 Cell viability was measured via the CellTiter 96® AQueous One Solution Cell 
Proliferation Assay (Promega). After each treatment, the assay was added to the culture 
medium and cells were incubated at 37°C. After incubation, absorption was measured on 
a microplate reader (Infinite 200, Tecan Trading AG, Switzerland) at 490 nm, with a 
reference wavelength of 675 nm to subtract background. 
RT-qPCR 
 To compare RNA levels between samples, RNA was isolated from cells using the 
RNeasy Mini Kit (Qiagen), purified with the Turbo DNA-free Kit (ThermoFisher), and 
reverse transcribed using the SuperScript® First-Strand Synthesis System 
(ThermoFisher). qPCR was performed using FastStart Universal SYBR Green Master 
Mix (Roche) with the primers listed in Table 1, and analyzed on an Applied Biosystems 
7300 Real Time PCR System. Relative RNA levels were normalized to the housekeeping 
gene Ribosomal Protein L27 (RPL27). The PCR conditions were as follows: 50°C for 2 
min for prevention of carryover contamination; 95°C for 10 min to activate the FastStart 
Taq DNA polymerase; 45 cycles of 95°C for 15s, 58°C for 18s, and 72°C for 30s for 
annealing, extension, and fluorescence reading; and one cycle of 95°C for 15s and 60°C 
for 1 min for amplification and real-time analysis. 
Amyloid-β, pTau/total tau measurements 
Three-week differentiated neurons were plated at 2 x 105 per well of a 96-well 
plate. Cells were cultured for an additional two weeks with no media change. On the 14th 
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day, full media change was performed, along with any drug treatments. Cells were 
cultured for an additional two to five days. Amyloid-β was measured with V-PLEX Aβ 
Peptide Panel 1 (6E10) Kit (Meso Scale Discovery). pTau/total tau was measured with a 
Phospho (Thr231)/Total Tau Kit (Meso Scale Discovery). Values were normalized to 
total protein levels determined by BCA assay (ThermoFisher). 
Statistics 
For each graph, statistics were performed by using either a one-way ANOVA 
with Dunnet correction for multiple comparisons, or by two-tailed Student’s t-test using 
GraphPad Prism 6. The data were presented as the mean ± SEM.  
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Table 1. Primers used for qPCR 
Primers 
Gene Primer Sequence 
RPL27 
F – ACATTGATGATGGCACCTCAG 
R – CCAAGGGGATATCCACAGAGT 
Non-spliced XBP-1 
F – ACTCAGACTACGTGCACCTCT 
R – GCTGGCAGGCTCTGGGGAAG 
Spliced XBP-1 
F – TGCTGAGTCCGCAGCAGGTG 
R – GCTGGCAGGCTCTGGGGAAG 
BiP 
F – CAAAGACATTTGCTCCTGAAGA 
R – TTGCCCGTCTTCTTTTTGTA 
CHOP 
F – CAGAGCTGGAACCTGAGGAG 
R – CAGTGTCCCGAAGGAGAAAG 
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